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Practice change amidst the COVID-19 pandemic: Harnessing 
the momentum for expanding telehealth in transplant
To the Editor:
On March 17, 2020, the Centers for Medicare & Medicaid Services 
invoked sweeping expansions to the nation's telehealth capacity, 
authorizing providers to bill for telehealth visits with Medicare ben-
eficiaries at cost parity to in-person visits, eliminating deductibles, 
and waiving penalties for non-HIPAA compliant communication 
platforms.1 While issued on a temporary and emergency basis, this 
policy provides an opportunity for the transplant community to ex-
plore permanent telehealth infrastructure.
Before the COVID-19 pandemic, our center's long-term goal 
was to increase utilization of telehealth to 20% of patient visits over 
5 years. COVID-19 has forced us to adapt rapidly. In 2019, we per-
formed 5 telehealth visits per month—in March 2020 alone we per-
formed 184, and have had over 475 telehealth visits in April. We 
moved the majority of our low-acuity patient visits to video or phone 
and are working on transitioning required transplant education 
classes to an interactive, virtual format. During the rapid expansion, 
we have been stressed by network traffic, availability of compatible 
technology, and billing concerns, yet we are overcoming these barri-
ers and have made lasting progress through a team-based approach 
to patient and provider education and technical support.
Long-term transplant telehealth plans at our institution were 
motivated by evidence that transplant telehealth programs may re-
duce costs, shorten time to initial evaluation and waitlist placement, 
improve quality of life, and decrease readmissions following trans-
plant.2,3 While these long-term goals still exist, the rapid roll-out has 
demonstrated additional benefits. Our video care teams are able to 
frequently check-in on patients with acute medical and surgical is-
sues and reinforce education on challenges like polypharmacy or low 
health literacy. Anecdotally, patients have been enthusiastic partici-
pants and have experienced no known adverse events. We are learn-
ing and honing best practices each day but will need to be rigorous in 
our interpretation of data and mindful of barriers.
As with any change in care delivery, telehealth services must 
not create or further disparities for the most vulnerable popula-
tions. Utilization of telehealth requires at a minimum access to a 
smartphone and/or Internet. Demographic factors including edu-
cation, age, language, and culture may all impact telehealth acces-
sibility. At the same time, some of the greatest disparities in the 
transplantation process occur with waitlist access. Distance from a 
transplant center has been associated with increased mortality.4 If 
implemented carefully, telehealth may increase access to our rural 
patients and reduce travel-related time and financial costs. There 
is also evidence that implementing telehealth measures focused on 
patients of lower socioeconomic status, creating tools accessible 
across broad ranges of literacy, and aiming for universal access to 
technology may allow telehealth expansion to be a solution rather 
than a barrier to access.5
As we move past COVID-19, our department is committed to 
advancing our infrastructure for telemedicine-based transplantation 
care. A crisis is an impetus for transformative change, and the cur-
rent pandemic should be seen as an opportunity to move telehealth 
forward. We can use this sudden change as a stimulus to discard 
outdated policies and innovate for the good of our patients.
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